Medication related nausea and vomiting in palliative medicine.

  title={Medication related nausea and vomiting in palliative medicine.},
  author={Erica Maceira and Timothy S. Lesar and Howard S. Smith},
  journal={Annals of palliative medicine},
  volume={1 2},
There are multiple potential states and/or symptoms that may occur in the palliative care population including: pain, nausea/vomiting, fatigue, anorexia, dyspnea, hiccups, cough, constipation, abdominal cramps/bloating, diarrhea, pruritis, depression/anxiety, dysphagia and sleep disturbances. Some of this may be the direct result of medications or drug-drug interactions from agents prescribed to treat the medical conditions that the patient has. Medication-related nausea and vomiting (MRNV) is… 
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research
The repurposing of different drugs for treatment of nausea and vomiting is examined, particularly during palliative care, and also the challenges in identifying novel anti-emetic drugs, particularly for Treatment of nausea as compared to vomiting.
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
Oral azacitidine maintenance had a generally favorable safety profile, and awareness of the type, onset, and duration of common AEs, and implementation of effective AE management, may maximize treatment adherence and optimize the survival benefits of oral azac itidine AML remission maintenance therapy.


Nausea and vomiting in HIV: a symptom review
The causes and management of these symptoms in HIV-infected patients and the need for further research in this area are reviewed and discussed.
Management of Opioid‐Induced Gastrointestinal Effects in Patients Receiving Palliative Care
A strong understanding of the pathophysiology of the sequelae is therefore paramount, and many pharmacotherapeutic agents available with which to prevent or treat these side effects are examined.
Nausea, Vomiting, and Retching: Complex Problems in Palliative Care
Patients with advanced cancer commonly experience nausea, vomiting, and/or retching (NVR) as a result of the malignant process and its treatment. Recently, increasing attention is being focused on
Nausea and vomiting in adults--a diagnostic approach.
The assessment and management of acute and chronic nausea and vomiting in adults is discussed, with a significant number of patients remaining undiagnosed despite extensive investigation.
Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
Nausea and vomiting side effects limit the analgesic efficiency of current opioid therapies and there is a clear need for the development of improved opioid-based analgesics that mitigate these intolerable effects.
Chemotherapy induced nausea and vomiting.
Further trials are needed to optimise the agents used, and in particular to overcome the problem of delayed nausea and vomiting.
Prevention and Treatment of Postoperative Nausea and Vomiting
This multimodal PONV management approach includes use of multiple different antiemetics medications (double or triple combination antiemetic therapy acting at different neuroreceptor sites); less emetogenic anaesthesia techniques; adequate intravenous hydration; and adequate pain control.
Management of common opioid-induced adverse effects.
Understanding the mechanism for opioid-induced nausea will aid in the selection of appropriate agents, and Physicians should minimize the development of constipation using prophylactic measures.
The prevalence of bowel problems reported in a palliative care population.
Disturbed bowel function consistently remains a problem for people under the care of palliative care services, with the proportion of people with severe problems increasing as death approaches, despite the time and number of interventions currently used to palliate these problems.
Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.
Well-designed trials in the specified populations are required to furnish clinicians with secure evidence on managing opioid side effects successfully, and the lack of well-designed, randomized controlled trials and the heterogeneity of populations and study designs made the drawing of firm conclusions difficult and precluded performance of meta-analysis.